Altria Group Valuation
Is MO * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
5/6Valuation Score 5/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of MO * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: MO * (MX$739.8) is trading below our estimate of fair value (MX$1001.3)
Significantly Below Fair Value: MO * is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for MO *?
Other financial metrics that can be useful for relative valuation.
What is MO *'s n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$74.87b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 4.7x |
Enterprise Value/EBITDA | 7.8x |
PEG Ratio | 3.5x |
Price to Earnings Ratio vs Peers
How does MO *'s PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 22.8x | ||
FEMSA UBD Fomento Económico Mexicano. de | 26.1x | 14.5% | Mex$662.0b |
BIMBO A Grupo Bimbo. de | 22.3x | 18.7% | Mex$306.9b |
AC * Arca Continental. de | 16.2x | 7.9% | Mex$284.3b |
ITC ITC | 26.6x | 8.5% | ₹5.4t |
MO * Altria Group | 8.9x | 2.5% | Mex$74.9b |
Price-To-Earnings vs Peers: MO * is good value based on its Price-To-Earnings Ratio (8.9x) compared to the peer average (22.8x).
Price to Earnings Ratio vs Industry
How does MO *'s PE Ratio compare vs other companies in the Global Tobacco Industry?
Price-To-Earnings vs Industry: MO * is good value based on its Price-To-Earnings Ratio (8.9x) compared to the Global Tobacco industry average (11.7x).
Price to Earnings Ratio vs Fair Ratio
What is MO *'s PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 8.9x |
Fair PE Ratio | 20.6x |
Price-To-Earnings vs Fair Ratio: MO * is good value based on its Price-To-Earnings Ratio (8.9x) compared to the estimated Fair Price-To-Earnings Ratio (20.6x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | Mex$739.80 | Mex$796.11 +7.6% | 18.4% | Mex$1,240.57 | Mex$620.28 | n/a | 13 |
Apr ’25 | Mex$722.32 | Mex$777.84 +7.7% | 17.9% | Mex$1,218.14 | Mex$602.39 | n/a | 14 |
Mar ’25 | Mex$696.86 | Mex$799.74 +14.8% | 18.2% | Mex$1,244.80 | Mex$615.58 | n/a | 14 |
Feb ’25 | Mex$711.80 | Mex$808.68 +13.6% | 18.0% | Mex$1,247.31 | Mex$616.82 | n/a | 14 |
Jan ’25 | Mex$682.01 | Mex$801.20 +17.5% | 15.4% | Mex$1,201.75 | Mex$635.21 | n/a | 16 |
Dec ’24 | Mex$730.00 | Mex$810.32 +11.0% | 15.4% | Mex$1,205.74 | Mex$637.32 | n/a | 16 |
Nov ’24 | Mex$725.94 | Mex$859.88 +18.5% | 15.3% | Mex$1,263.75 | Mex$667.98 | n/a | 17 |
Oct ’24 | Mex$732.00 | Mex$867.23 +18.5% | 13.4% | Mex$1,229.89 | Mex$650.09 | n/a | 17 |
Sep ’24 | n/a | Mex$833.03 0% | 13.5% | Mex$1,177.19 | Mex$622.23 | n/a | 17 |
Aug ’24 | Mex$765.00 | Mex$850.69 +11.2% | 14.1% | Mex$1,204.71 | Mex$636.77 | n/a | 17 |
Jul ’24 | Mex$780.00 | Mex$850.69 +9.1% | 14.1% | Mex$1,204.71 | Mex$636.77 | n/a | 17 |
Jun ’24 | Mex$778.00 | Mex$867.80 +11.5% | 14.1% | Mex$1,228.74 | Mex$649.48 | n/a | 16 |
May ’24 | Mex$855.00 | Mex$912.79 +6.8% | 12.6% | Mex$1,262.25 | Mex$685.22 | Mex$748.00 | 15 |
Apr ’24 | Mex$804.00 | Mex$913.74 +13.6% | 12.9% | Mex$1,261.57 | Mex$684.85 | Mex$722.32 | 14 |
Mar ’24 | Mex$869.50 | Mex$922.07 +6.0% | 14.0% | Mex$1,296.09 | Mex$685.07 | Mex$696.86 | 16 |
Feb ’24 | Mex$880.06 | Mex$919.41 +4.5% | 14.1% | Mex$1,303.47 | Mex$688.98 | Mex$711.80 | 16 |
Jan ’24 | Mex$890.00 | Mex$975.02 +9.6% | 14.1% | Mex$1,346.22 | Mex$732.50 | Mex$682.01 | 16 |
Dec ’23 | Mex$880.00 | Mex$950.25 +8.0% | 14.4% | Mex$1,320.40 | Mex$718.45 | Mex$730.00 | 16 |
Nov ’23 | Mex$913.70 | Mex$993.63 +8.7% | 15.3% | Mex$1,347.38 | Mex$713.32 | Mex$725.94 | 17 |
Oct ’23 | Mex$846.00 | Mex$999.94 +18.2% | 15.7% | Mex$1,359.12 | Mex$719.53 | Mex$732.00 | 17 |
Sep ’23 | Mex$915.94 | Mex$999.94 +9.2% | 15.7% | Mex$1,359.12 | Mex$719.53 | n/a | 17 |
Aug ’23 | n/a | Mex$1,024.84 0% | 15.8% | Mex$1,386.12 | Mex$733.83 | Mex$765.00 | 17 |
Jul ’23 | Mex$843.00 | Mex$1,063.56 +26.2% | 15.1% | Mex$1,367.30 | Mex$723.87 | Mex$780.00 | 17 |
Jun ’23 | Mex$1,083.22 | Mex$1,132.88 +4.6% | 7.7% | Mex$1,348.44 | Mex$1,031.16 | Mex$778.00 | 17 |
May ’23 | Mex$1,141.07 | Mex$1,148.75 +0.7% | 8.7% | Mex$1,387.79 | Mex$918.39 | Mex$855.00 | 16 |
Analyst Forecast: Target price is less than 20% higher than the current share price.